vs
Alignment Healthcare, Inc.（ALHC）与CF Industries（CF）财务数据对比。点击上方公司名可切换其他公司
CF Industries的季度营收约是Alignment Healthcare, Inc.的1.6倍（$2.0B vs $1.2B），CF Industries净利率更高（31.0% vs 0.9%，领先30.0%），CF Industries同比增速更快（19.4% vs -74.7%），过去两年Alignment Healthcare, Inc.的营收复合增速更高（34.6% vs 12.4%）
Alignment Healthcare是总部位于美国的医疗保健企业，主打联邦医疗保险优势计划，为老年群体提供协调医疗服务、处方药保障及补充福利，采用价值导向医疗模式，与本土医疗机构合作，业务覆盖美国多个州，致力提升患者健康水平。
CF Industries Holdings Inc.是美国知名农用肥料生产及分销商，1946年成立时名为中央农民肥料公司，总部位于芝加哥郊区的伊利诺伊州诺斯布鲁克。公司主营氨、尿素、硝酸铵等肥料产品，最初为区域农业供应合作社联盟，成立56年后完成股份化改制，转为公开上市企业。
ALHC vs CF — 直观对比
营收规模更大
CF
是对方的1.6倍
$1.2B
营收增速更快
CF
高出94.2%
-74.7%
净利率更高
CF
高出30.0%
0.9%
两年增速更快
ALHC
近两年复合增速
12.4%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $2.0B |
| 净利润 | $11.4M | $615.0M |
| 毛利率 | — | 37.6% |
| 营业利润率 | — | 43.5% |
| 净利率 | 0.9% | 31.0% |
| 营收同比 | -74.7% | 19.4% |
| 净利润同比 | — | 97.1% |
| 每股收益（稀释后） | — | $3.98 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALHCCF
| Q1 26 | $1.2B | $2.0B | ||
| Q4 25 | $1.0B | $1.9B | ||
| Q3 25 | $993.7M | $1.7B | ||
| Q2 25 | $1.0B | $1.9B | ||
| Q1 25 | $926.9M | $1.7B | ||
| Q4 24 | $701.2M | $1.5B | ||
| Q3 24 | $692.4M | $1.4B | ||
| Q2 24 | $681.3M | $1.6B |
净利润ALHCCF
| Q1 26 | $11.4M | $615.0M | ||
| Q4 25 | $-11.0M | $495.0M | ||
| Q3 25 | $3.7M | $460.0M | ||
| Q2 25 | $15.7M | $492.0M | ||
| Q1 25 | $-9.1M | $351.0M | ||
| Q4 24 | $-31.1M | $392.0M | ||
| Q3 24 | $-26.4M | $341.0M | ||
| Q2 24 | $-24.0M | $506.0M |
毛利率ALHCCF
| Q1 26 | — | 37.6% | ||
| Q4 25 | — | 40.9% | ||
| Q3 25 | — | 38.1% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | — | 34.4% | ||
| Q4 24 | — | 34.4% | ||
| Q3 24 | — | 32.4% | ||
| Q2 24 | — | 43.2% |
营业利润率ALHCCF
| Q1 26 | — | 43.5% | ||
| Q4 25 | -1.0% | 33.0% | ||
| Q3 25 | 0.8% | 35.0% | ||
| Q2 25 | 2.2% | 34.3% | ||
| Q1 25 | -0.6% | 27.4% | ||
| Q4 24 | -3.2% | 28.9% | ||
| Q3 24 | -2.8% | 26.6% | ||
| Q2 24 | -2.7% | 40.6% |
净利率ALHCCF
| Q1 26 | 0.9% | 31.0% | ||
| Q4 25 | -1.1% | 26.4% | ||
| Q3 25 | 0.4% | 27.7% | ||
| Q2 25 | 1.5% | 26.0% | ||
| Q1 25 | -1.0% | 21.1% | ||
| Q4 24 | -4.4% | 25.7% | ||
| Q3 24 | -3.8% | 24.9% | ||
| Q2 24 | -3.5% | 32.2% |
每股收益（稀释后）ALHCCF
| Q1 26 | — | $3.98 | ||
| Q4 25 | $-0.04 | $2.56 | ||
| Q3 25 | $0.02 | $2.19 | ||
| Q2 25 | $0.07 | $2.37 | ||
| Q1 25 | $-0.05 | $1.85 | ||
| Q4 24 | $-0.15 | $1.86 | ||
| Q3 24 | $-0.14 | $1.55 | ||
| Q2 24 | $-0.13 | $2.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $705.6M | — |
| 总债务越低越好 | — | $3.2B |
| 股东权益账面价值 | $206.9M | $5.3B |
| 总资产 | $1.3B | $14.6B |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资ALHCCF
| Q1 26 | $705.6M | — | ||
| Q4 25 | $604.2M | — | ||
| Q3 25 | $644.1M | — | ||
| Q2 25 | $503.8M | — | ||
| Q1 25 | $479.5M | — | ||
| Q4 24 | $470.6M | — | ||
| Q3 24 | $381.0M | — | ||
| Q2 24 | $363.7M | — |
总债务ALHCCF
| Q1 26 | — | $3.2B | ||
| Q4 25 | $323.2M | $3.2B | ||
| Q3 25 | $322.7M | $3.0B | ||
| Q2 25 | $322.3M | $3.0B | ||
| Q1 25 | $321.9M | $3.0B | ||
| Q4 24 | $321.4M | $3.0B | ||
| Q3 24 | $212.0M | $3.0B | ||
| Q2 24 | $211.7M | $3.0B |
股东权益ALHCCF
| Q1 26 | $206.9M | $5.3B | ||
| Q4 25 | $179.3M | $4.8B | ||
| Q3 25 | $161.9M | $4.8B | ||
| Q2 25 | $141.0M | $5.0B | ||
| Q1 25 | $108.1M | $4.8B | ||
| Q4 24 | $99.9M | $5.0B | ||
| Q3 24 | $114.5M | $5.2B | ||
| Q2 24 | $123.7M | $5.5B |
总资产ALHCCF
| Q1 26 | $1.3B | $14.6B | ||
| Q4 25 | $1.1B | $14.1B | ||
| Q3 25 | $1.1B | $14.2B | ||
| Q2 25 | $1.0B | $13.8B | ||
| Q1 25 | $895.6M | $13.3B | ||
| Q4 24 | $782.1M | $13.5B | ||
| Q3 24 | $692.3M | $13.8B | ||
| Q2 24 | $716.3M | $13.8B |
负债/权益比ALHCCF
| Q1 26 | — | 0.60× | ||
| Q4 25 | 1.80× | 0.66× | ||
| Q3 25 | 1.99× | 0.61× | ||
| Q2 25 | 2.29× | 0.60× | ||
| Q1 25 | 2.98× | 0.62× | ||
| Q4 24 | 3.22× | 0.60× | ||
| Q3 24 | 1.85× | 0.57× | ||
| Q2 24 | 1.71× | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $128.7M | $496.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.7B |
| 自由现金流率自由现金流/营收 | — | 83.2% |
| 资本支出强度资本支出/营收 | — | 11.2% |
| 现金转化率经营现金流/净利润 | 11.27× | 0.81× |
| 过去12个月自由现金流最近4个季度 | — | $3.0B |
8季度趋势，按日历期对齐
经营现金流ALHCCF
| Q1 26 | $128.7M | $496.0M | ||
| Q4 25 | $-50.4M | $539.0M | ||
| Q3 25 | $144.6M | $1.1B | ||
| Q2 25 | $29.1M | $563.0M | ||
| Q1 25 | $16.6M | $586.0M | ||
| Q4 24 | $-8.7M | $420.0M | ||
| Q3 24 | $26.2M | $931.0M | ||
| Q2 24 | $23.5M | $475.0M |
自由现金流ALHCCF
| Q1 26 | — | $1.7B | ||
| Q4 25 | $-55.4M | $313.0M | ||
| Q3 25 | $139.1M | $717.0M | ||
| Q2 25 | $21.1M | $318.0M | ||
| Q1 25 | $8.4M | $454.0M | ||
| Q4 24 | $-18.0M | $223.0M | ||
| Q3 24 | $16.9M | $792.0M | ||
| Q2 24 | $11.8M | $391.0M |
自由现金流率ALHCCF
| Q1 26 | — | 83.2% | ||
| Q4 25 | -5.5% | 16.7% | ||
| Q3 25 | 14.0% | 43.2% | ||
| Q2 25 | 2.1% | 16.8% | ||
| Q1 25 | 0.9% | 27.3% | ||
| Q4 24 | -2.6% | 14.6% | ||
| Q3 24 | 2.4% | 57.8% | ||
| Q2 24 | 1.7% | 24.9% |
资本支出强度ALHCCF
| Q1 26 | — | 11.2% | ||
| Q4 25 | 0.5% | 12.1% | ||
| Q3 25 | 0.6% | 20.9% | ||
| Q2 25 | 0.8% | 13.0% | ||
| Q1 25 | 0.9% | 7.9% | ||
| Q4 24 | 1.3% | 12.9% | ||
| Q3 24 | 1.3% | 10.1% | ||
| Q2 24 | 1.7% | 5.3% |
现金转化率ALHCCF
| Q1 26 | 11.27× | 0.81× | ||
| Q4 25 | — | 1.09× | ||
| Q3 25 | 38.77× | 2.31× | ||
| Q2 25 | 1.86× | 1.14× | ||
| Q1 25 | — | 1.67× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 2.73× | ||
| Q2 24 | — | 0.94× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALHC
暂无分部数据
CF
| EBITDA | $1.0B | 51% |
| Other | $975.0M | 49% |
| Loss on foreign currency transactions | $3.0M | 0% |
